Professor Michael John Kennedy
Clinical Professor, Clinical Medicine

Cahir, C. Dombrowski, S.U. Kelly, C.M. Kennedy, M.J. Bennett, K. Sharp, L., Women-s experiences of hormonal therapy for breast cancer: exploring influences on medication-taking behaviour, Irish Journal of Medical Science, 2015 Journal Article, 2015 DOI URL

Guinan, E.M. Connolly, E.M. Healy, L.A. Carroll, P.A. Kennedy, M.J. Hussey, J., The development of the metabolic syndrome and insulin resistance after adjuvant treatment for breast cancer, Cancer Nursing, 37, (5), 2014, p355 - 362 Journal Article, 2014 DOI URL

Pooley, K.A. McGuffog, L. Barrowdale, D. Frost, D. Ellis, S.D. Fineberg, E. Platte, R. Izatt, L. Adlard, J. Bardwell, J. Brewer, C. Cole, T. Cook, J. Davidson, R. Donaldson, A. Dorkins, H. Douglas, F. Eason, J. Houghton, C. Kennedy, M.J. McCann, E. Miedzybrodzka, Z. Murray, A. Porteous, M.E. Rogers, M.T. Side, L.E. Tischkowitz, M. Walker, L. Hodgson, S. Eccles, D.M. Morrison, P.J. Evans, D.G. Eeles, R.A. Antoniou, A.C. Easton, D.F. Dunning, A.M., Lymphocyte telomere length is long in BRCA1 and BRCA2 mutation carriers regardless of cancer-affected status, Cancer Epidemiology, Biomarkers & Prevention, 23, (6), 2014, p1018 - 1024 Journal Article, 2014 DOI URL

Broderick JM, Hussey J, Kennedy MJ, O' Donnell DM, Patients over 65 years are assigned lower ECOG PS scores than younger patients, although objectively measured physical activity is no different, Geriatric Oncology, 5, (1), 2014, p49-56 Journal Article, 2014 DOI TARA - Full Text

O'Brien C, Dempsey O, Kennedy MJ, Febrile Neutropenia risk assessment tool: Improving clinical outcomes for oncology patients, European Journal of Oncology Nursing , 18, (2), 2014, p167-174 Journal Article, 2014 DOI

J. M. Broderick, J. Hussey, M. J. Kennedy, D. M. O' Donnell. , Testing the 'teachable moment' premise: does physical activity increase in the early survivorship phase? , Supportive Care in Cancer, 22, (4), 2014, p989-997 Journal Article, 2014 URL TARA - Full Text DOI

Crown, J. Kennedy, M.J. Tresca, P. Marty, M. Espie, M. Burris, H.A. DeSilvio, M. Lau, M.R. Kothari, D. Koch, K.M. Diéras, V., Optimally tolerated dose of lapatinib in combinationwith docetaxel plus trastuzumab in first-line treatmentof HER2-positive metastatic breast cancer, Annals of Oncology, 24, (8), 2013, p2005 - 2011 Journal Article, 2013 URL DOI TARA - Full Text

Mavaddat, N. Peock, S. Frost, D. Ellis, S. Platte, R. Fineberg, E. Evans, D.G. Izatt, L. Eeles, R.A. Adlard, J. Davidson, R. Eccles, D. Cole, T. Cook, J. Brewer, C. Tischkowitz, M. Douglas, F. Hodgson, S. Walker, L. Porteous, M.E. Morrison, P.J. Side, L.E. Kennedy, M.J. Houghton, C. Donaldson, A. Rogers, M.T. Dorkins, H. Miedzybrodzka, Z. Gregory, H. Eason, J. Barwell, J. McCann, E. Murray, A. Antoniou, A.C. Easton, D.F., Cancer risks for BRCA1 and BRCA2 mutation carriers: Results from prospective analysis of EMBRACE, Journal of the National Cancer Institute, 105, (11), 2013, p812 - 822 Journal Article, 2013 TARA - Full Text URL DOI

Castro, E. Goh, C. Olmos, D. Saunders, E. Leongamornlert, D. Tymrakiewicz, M. Mahmud, N. Dadaev, T. Govindasami, K. Guy, M. Sawyer, E. Wilkinson, R. Ardern-Jones, A. Ellis, S. Frost, D. Peock, S. Evans, D.G. Tischkowitz, M. Cole, T. Davidson, R. Eccles, D. Brewer, C. Douglas, F. Porteous, M.E. Donaldson, A. Dorkins, H. Izatt, L. Cook, J. Hodgson, S. Kennedy, M.J. Side, L.E. Eason, J. Murray, A. Antoniou, A.C. Easton, D.F. Kote-Jarai, Z. Eeles, R., Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer., Journal of Clinical Oncology, 31, (14), 2013, p1748 - 1757 Journal Article, 2013 DOI URL

Guinan E, Hussey J, Broderick JM, Lithander FE, O'Donnell D, Kennedy MJ, Connolly EM, The effect of aerobic exercise on metabolic and inflammatory markers in breast cancer survivors-a pilot study., Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 21, (7), 2013, p1983-1992 Journal Article, 2013 DOI TARA - Full Text URL

Pertl, M.M., Hevey, D., Boyle, N.T., Hughes, M.M., Collier, S., O'Dwyer, A.M., Harkin, A., Kennedy, M.J., & Connor, T.J., C-reactive prtoein predicts fatigue independently of depression in breast cancer patients prior to chemotherapy, Brain Behaviour and Immunity, 34, 2013, p108 - 119 Journal Article, 2013 DOI

Castro, E. Goh, C. Olmos, D. Saunders, E. Leongamornlert, D. Tymrakiewicz, M. Mahmud, N. Dadaev, T. Govindasami, K. Guy, M. Sawyer, E. Wilkinson, R. Ardern-Jones, A. Ellis, S. Frost, D. Peock, S. Evans, D.G. Tischkowitz, M. Cole, T. Davidson, R. Eccles, D. Brewer, C. Douglas, F. Porteous, M.E. Donaldson, A. Dorkins, H. Izatt, L. Cook, J. Hodgson, S. Kennedy, M.J. Side, L.E. Eason, J. Murray, A. Antoniou, A.C. Easton, D.F. Kote-Jarai, Z. Eeles, R., Re: Germline brca mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer, The Journal of Urology, 190, (6), 2013, p2093- Journal Article, 2013 DOI URL

Baselga, J. Gómez, P. Greil, R. Braga, S. Climent, M.A. Wardley, A.M. Kaufman, B. Stemmer, S.M. Pêgo, A. Chan, A. Goeminne, J.C. Graas, M.P. Kennedy, M.J. Ciruelos Gil, E.M. Schneeweiss, A. Zubel, A. Groos, J. Melezínková, H. Awada, A., Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer., Journal of Clinical Oncology, 31, (20), 2013, p2586 - 2592 Journal Article, 2013 URL DOI

Broderick, J.M. Guinan, E. Kennedy, M.J. Hollywood, D. Courneya, K.S. Culos-Reed, S.N. Bennett, K. O' Donnell, D.M. Hussey, J., Feasibility and efficacy of a supervised exercise intervention in de-conditioned cancer survivors during the early survivorship phase: The PEACH trial, Journal of Cancer Survivorship, 7, (4), 2013, p551 - 562 Journal Article, 2013 URL DOI

Guinan EM, Connolly EM, Kennedy MJ, Hussey J, The presentation of metabolic dysfunction and the relationship with energy output in breast cancer survivors: a cross-sectional study., Nutrition journal, 12, (1), 2013, p99 Journal Article, 2013 TARA - Full Text DOI

Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, Skytte AB, Caligo MA, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, Nathanson KL, Rebbeck TR, Jakubowska A, Lubinski J, Jaworska K, Durda K, Z"owocka E, Gronwald J, Huzarski T, Byrski T, Cybulski C, Toloczko-Grabarek A, Osorio A, Benitez J, Duran M, Tejada MI, Hamann U, Rookus M, van Leeuwen FE, Aalfs CM, Meijers-Heijboer HE, van Asperen CJ, van Roozendaal KE, Hoogerbrugge N, Collée JM, Kriege M, van der Luijt RB, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Lalloo F, Jacobs C, Eeles R, Adlard J, Davidson R, Eccles D, Cole T, Cook J, Paterson J, Douglas F, Brewer C, Hodgson S, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Pathak H, Godwin AK, Stoppa-Lyonnet D, Caux-Moncoutier V, de Pauw A, Gauthier-Villars M, Mazoyer S, Léoné M, Calender A, Lasset C, Bonadona V, Hardouin A, Berthet P, Bignon YJ, Uhrhammer N, Faivre L, Loustalot C, Buys S, Daly M, Miron A, Terry MB, Chung WK, John EM, Southey M, Goldgar D, Singer CF, Tea MK, Pfeiler G, Fink-Retter A, Hansen Tv, Ejlertsen B, Johannsson OT, Offit K, Kirchhoff T, Gaudet MM, Vijai J, Robson M, Piedmonte M, Phillips KA, Van Le L, Hoffman JS, Ewart Toland A, Montagna M, Tognazzo S, Imyanitov E, Issacs C, Janavicius R, Lazaro C, Blanco I, Tornero E, Navarro M, Moysich KB, Karlan BY, Gross J, Olah E, Vaszko T, Teo SH, Ganz PA, Beattie MS, Dorfling CM, van Rensburg EJ, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Schäfer D, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Plante M, Spurdle AB, Neuhausen SL, Ding YC, Wang X, Lindor N, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Bernard L, Dolcetti R, Papi L, Ottini L, Radice P, Greene MH, Mai PL, Andrulis IL, Glendon G, Ozcelik H, Pharoah PD, Gayther SA, Simard J, Easton DF, Couch FJ, Chenevix-Trench G, Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers., Human mutation, 33, (4), 2012, p690-702 Journal Article, 2012

Dowling P, Clarke C, Hennessy K, Torralbo-Lopez B, Ballot J, Crown J, Kiernan I, O'Byrne KJ, Kennedy MJ, Lynch V, Clynes M, Analysis of acute-phase proteins, AHSG, C3, CLI, HP and SAA, reveals distinctive expression patterns associated with breast, colorectal and lung cancer., International journal of cancer. Journal international du cancer, 131, (4), 2012, p911-23 Journal Article, 2012

Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, Andrulis IL, Ozcelik H, Mulligan AM, Thomassen M, Gerdes AM, Jensen UB, Skytte AB, Kruse TA, Caligo MA, von Wachenfeldt A, Barbany-Bustinza G, Loman N, Soller M, Ehrencrona H, Karlsson P, Nathanson KL, Rebbeck TR, Domchek SM, Jakubowska A, Lubinski J, Jaworska K, Durda K, Zlowocka E, Huzarski T, Byrski T, Gronwald J, Cybulski C, Górski B, Osorio A, Durán M, Tejada MI, Benitez J, Hamann U, Hogervorst FB, van Os TA, van Leeuwen FE, Meijers-Heijboer HE, Wijnen J, Blok MJ, Kets M, Hooning MJ, Oldenburg RA, Ausems MG, Peock S, Frost D, Ellis SD, Platte R, Fineberg E, Evans DG, Jacobs C, Eeles RA, Adlard J, Davidson R, Eccles DM, Cole T, Cook J, Paterson J, Brewer C, Douglas F, Hodgson SV, Morrison PJ, Walker L, Porteous ME, Kennedy MJ, Side LE, Bove B, Godwin AK, Stoppa-Lyonnet D, Fassy-Colcombet M, Castera L, Cornelis F, Mazoyer S, Léoné M, Boutry-Kryza N, Bressac-de Paillerets B, Caron O, Pujol P, Coupier I, Delnatte C, Akloul L, Lynch HT, Snyder CL, Buys SS, Daly MB, Terry M, Chung WK, John EM, Miron A, Southey MC, Hopper JL, Goldgar DE, Singer CF, Rappaport C, Tea MK, Fink-Retter A, Hansen TV, Nielsen FC, Arason A, Vijai J, Shah S, Sarrel K, Robson ME, Piedmonte M, Phillips K, Basil J, Rubinstein WS, Boggess J, Wakeley K, Ewart-Toland A, Montagna M, Agata S, Imyanitov EN, Isaacs C, Janavicius R, Lazaro C, Blanco I, Feliubadalo L, Brunet J, Gayther SA, Pharoah PP, Odunsi KO, Karlan BY, Walsh CS, Olah E, Teo SH, Ganz PA, Beattie MS, van Rensburg EJ, Dorfling CM, Diez O, Kwong A, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ditsch N, Arnold N, Heidemann S, Niederacher D, Preisler-Adams S, Gadzicki D, Varon-Mateeva R, Deissler H, Gehrig A, Sutter C, Kast K, Fiebig B, Heinritz W, Caldes T, de la Hoya M, Muranen TA, Nevanlinna H, Tischkowitz MD, Spurdle AB, Neuhausen SL, Ding YC, Lindor NM, Fredericksen Z, Pankratz VS, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Barile M, Bernard L, Viel A, Giannini G, Varesco L, Radice P, Greene MH, Mai PL, Easton DF, Chenevix-Trench G, Offit K, Simard J, Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers., Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 21, (4), 2012, p645-57 Journal Article, 2012

Farrell MP, Hughes DJ, Berry IR, Gallagher DJ, Glogowski EA, Payne SJ, Kennedy MJ, Clarke RM, White SA, Muldoon CB, Macdonald F, Rehal P, Crompton D, Roring S, Duke ST, McDevitt T, Barton DE, Hodgson SV, Green AJ, Daly PA, Clinical correlation and molecular evaluation confirm that the MLH1 p.Arg182Gly (c.544A>G) mutation is pathogenic and causes Lynch syndrome., Familial cancer, 11, (3), 2012, p509-18 Journal Article, 2012

Woods R, Larkin JO, Muldoon C, Kennedy MJ, Mehigan B, McCormick P, Metastatic paediatric colorectal carcinoma., Irish medical journal, 105, (3), 2012, p88-9 Journal Article, 2012

Osorio A, Milne RL, Alonso R, Pita G, Peterlongo P, Teulé A, Nathanson KL, Domchek SM, Rebbeck T, Lasa A, Konstantopoulou I, Hogervorst FB, Verhoef S, van Dooren MF, Jager A, Ausems MG, Aalfs CM, van Asperen CJ, Vreeswijk M, Waisfisz Q, Van Roozendaal CE, Ligtenberg MJ, Easton DF, Peock S, Cook M, Oliver CT, Frost D, Curzon B, Evans DG, Lalloo F, Eeles R, Izatt L, Davidson R, Adlard J, Eccles D, Ong KR, Douglas F, Downing S, Brewer C, Walker L, Nevanlinna H, Aittomäki K, Couch FJ, Fredericksen Z, Lindor NM, Godwin A, Isaacs C, Caligo MA, Loman N, Jernström H, Barbany-Bustinza G, Liljegren A, Ehrencrona H, Stenmark-Askmalm M, Feliubadaló L, Manoukian S, Peissel B, Zaffaroni D, Bonanni B, Fortuzzi S, Johannsson OT, Chenevix-Trench G, Chen XC, Beesley J, Spurdle AB, Sinilnikova OM, Healey S, McGuffog L, Antoniou AC, Brunet J, Radice P, Benítez J, Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2., British journal of cancer, 104, (8), 2011, p1356-61 Journal Article, 2011

Collins IM, Fay L, Kennedy MJ, Strategies for fertility preservation after chemotherapy: awareness among Irish cancer specialists., Irish medical journal, 104, (1), 2011, p6-9 Journal Article, 2011

Maughan TS, Adams RA, Smith CG, Meade AM, Seymour MT, Wilson RH, Idziaszczyk S, Harris R, Fisher D, Kenny SL, Kay E, Mitchell JK, Madi A, Jasani B, James MD, Bridgewater J, Kennedy MJ, Claes B, Lambrechts D, Kaplan R, Cheadle JP, Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial., Lancet, 377, (9783), 2011, p2103-14 Journal Article, 2011

Carroll PA, Nolan C, Clarke R, Farrell M, Gleeson N, Boyle T, Dunne B, Daly PA, Kennedy MJ, Connolly EM, Surgical management of an Irish cohort of BRCA-mutation carriers., Breast (Edinburgh, Scotland), 20, (5), 2011, p419-23 Journal Article, 2011

Carroll PA, O'Mahony D, McDermott R, Boyle T, Dunne B, Kennedy MJ, Connolly EM, Perioperative diagnosis of the positive axilla in breast cancer: a safe, time efficient algorithm., European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 37, (3), 2011, p205-10 Journal Article, 2011 DOI

Carroll PA, Healy L, Lysaght J, Boyle T, Reynolds JV, Kennedy MJ, Pidgeon G, Connolly EM., Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer., Molecular Carcinogenesis, 50, (8), 2011, p643 - 651 Journal Article, 2011 DOI

Adams RA, Meade AM, Seymour MT, Wilson RH, Madi A, Fisher D, Kenny SL, Kay E, Hodgkinson E, Pope M, Rogers P, Wasan H, Falk S, Gollins S, Hickish T, Bessell EM, Propper D, Kennedy MJ, Kaplan R, Maughan TS, Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial., The lancet oncology, 12, (7), 2011, p642-53 Journal Article, 2011

Carroll PA, Healy L, Lysaght J, Boyle T, Reynolds JV, Kennedy MJ, Pidgeon G, Connolly EM, Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer., Molecular carcinogenesis, 50, (8), 2011, p643-51 Journal Article, 2011

Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Allavena A, Ottini L, Papi L, Gismondi V, Capra F, Radice P, Greene MH, Mai PL, Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA, Cruger D, Jensen UB, Caligo MA, Olsson H, Kristoffersson U, Lindblom A, Arver B, Karlsson P, Stenmark Askmalm M, Borg A, Neuhausen SL, Ding YC, Nathanson KL, Domchek SM, Jakubowska A, Lubi"ski J, Huzarski T, Byrski T, Gronwald J, Górski B, Cybulski C, D"bniak T, Osorio A, Durán M, Tejada MI, Benítez J, Hamann U, Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Bodmer D, Ausems MG, van Os TA, Asperen CJ, Blok MJ, Meijers-Heijboer HE, Peock S, Cook M, Oliver C, Frost D, Dunning AM, Evans DG, Eeles R, Pichert G, Cole T, Hodgson S, Brewer C, Morrison PJ, Porteous M, Kennedy MJ, Rogers MT, Side LE, Donaldson A, Gregory H, Godwin A, Stoppa-Lyonnet D, Moncoutier V, Castera L, Mazoyer S, Barjhoux L, Bonadona V, Leroux D, Faivre L, Lidereau R, Nogues C, Bignon YJ, Prieur F, Collonge-Rame MA, Venat-Bouvet L, Fert-Ferrer S, Miron A, Buys SS, Hopper JL, Daly MB, John EM, Terry MB, Goldgar D, Hansen Tv, Jønson L, Ejlertsen B, Agnarsson BA, Offit K, Kirchhoff T, Vijai J, Dutra-Clarke AV, Przybylo JA, Montagna M, Casella C, Imyanitov EN, Janavicius R, Blanco I, Lázaro C, Moysich KB, Karlan BY, Gross J, Beattie MS, Schmutzler R, Wappenschmidt B, Meindl A, Ruehl I, Fiebig B, Sutter C, Arnold N, Deissler H, Varon-Mateeva R, Kast K, Niederacher D, Gadzicki D, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Simard J, Soucy P, Spurdle AB, Holland H, Chenevix-Trench G, Easton DF, Antoniou AC, Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers., Journal of the National Cancer Institute, 103, (2), 2011, p105-16 Journal Article, 2011

Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, Antoniou AC, Peock S, Evans DG, Paterson J, Kennedy MJ, Donaldson A, Dorkins H, Easton DF, Rubinstein WS, Daly MB, Isaacs C, Nevanlinna H, Couch FJ, Andrulis IL, Freidman E, Laitman Y, Ganz PA, Tomlinson GE, Neuhausen SL, Narod SA, Phelan CM, Greenberg R, Nathanson KL, Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes., Cancer research, 71, (17), 2011, p5792-805 Journal Article, 2011

Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, Dolcetti R, Giannini G, Putignano AL, Varesco L, Radice P, Mai PL, Greene MH, Andrulis IL, Glendon G, Ozcelik H, Thomassen M, Gerdes AM, Kruse TA, Birk Jensen U, Crüger DG, Caligo MA, Laitman Y, Milgrom R, Kaufman B, Paluch-Shimon S, Friedman E, Loman N, Harbst K, Lindblom A, Arver B, Ehrencrona H, Melin B, Nathanson KL, Domchek SM, Rebbeck T, Jakubowska A, Lubinski J, Gronwald J, Huzarski T, Byrski T, Cybulski C, Gorski B, Osorio A, Ramón y Cajal T, Fostira F, Andrés R, Benitez J, Hamann U, Hogervorst FB, Rookus MA, Hooning MJ, Nelen MR, van der Luijt RB, van Os TA, van Asperen CJ, Devilee P, Meijers-Heijboer HE, Gómez Garcia EB, Peock S, Cook M, Frost D, Platte R, Leyland J, Evans DG, Lalloo F, Eeles R, Izatt L, Adlard J, Davidson R, Eccles D, Ong KR, Cook J, Douglas F, Paterson J, Kennedy MJ, Miedzybrodzka Z, Godwin A, Stoppa-Lyonnet D, Buecher B, Belotti M, Tirapo C, Mazoyer S, Barjhoux L, Lasset C, Leroux D, Faivre L, Bronner M, Prieur F, Nogues C, Rouleau E, Pujol P, Coupier I, Frénay M, Hopper JL, Daly MB, Terry MB, John EM, Buys SS, Yassin Y, Miron A, Goldgar D, Singer CF, Tea MK, Pfeiler G, Dressler AC, Hansen Tv, Jønson L, Ejlertsen B, Barkardottir RB, Kirchhoff T, Offit K, Piedmonte M, Rodriguez G, Small L, Boggess J, Blank S, Basil J, Azodi M, Toland AE, Montagna M, Tognazzo S, Agata S, Imyanitov E, Janavicius R, Lazaro C, Blanco I, Pharoah PD, Sucheston L, Karlan BY, Walsh CS, Olah E, Bozsik A, Teo SH, Seldon JL, Beattie MS, van Rensburg EJ, Sluiter MD, Diez O, Schmutzler RK, Wappenschmidt B, Engel C, Meindl A, Ruehl I, Varon-Mateeva R, Kast K, Deissler H, Niederacher D, Arnold N, Gadzicki D, Schönbuchner I, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Dumont M, Chiquette J, Tischkowitz M, Chen X, Beesley J, Spurdle AB, Neuhausen SL, Chun Ding Y, Fredericksen Z, Wang X, Pankratz VS, Couch F, Simard J, Easton DF, Chenevix-Trench G, Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers., Human molecular genetics, 20, (16), 2011, p3304-21 Journal Article, 2011

Hassan SJ, Knox M, Griffin M, Kennedy MJ, Spontaneous regression of metastatic Merkel cell carcinoma., Irish medical journal, 103, (1), 2010, p21-2 Journal Article, 2010

Johnston S, Pippen J, Pivot X, Lichinitser M, Sadeghi S, Dieras V, Gomez HL, Romieu G, Manikhas A, Kennedy MJ, Press MF, Maltzman J, Florance A, O'Rourke L, Oliva C, Stein S, Pegram M, Lapatinib combined with letrozole versus letrozole and placebo as first-line therapy for postmenopausal hormone receptor-positive metastatic breast cancer., Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 27, (33), 2009, p5538-46 Journal Article, 2009

Morris PG, King F, Kennedy MJ, Cytotoxic chemotherapy for pregnancy-associated breast cancer: single institution case series., Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 15, (4), 2009, p241-7 Journal Article, 2009

Morris PG, O'Connor M, O'Rafferty C, Sheikh R, Gray J, McDermott R, Boyle T, Kennedy MJ, The excessive cost of baseline diagnostic imaging in early breast cancer., Irish medical journal, 102, (5), 2009, p149-52 Journal Article, 2009

Power DG, McVey GP, Delaney DW, Rea D, D'arcy T, Daly PA, Kennedy MJ, Papillary serous carcinomas of the uterine cervix and paraneoplastic cerebellar degeneration: a report of two cases., Acta oncologica (Stockholm, Sweden), 47, (8), 2008, p1590-3 Journal Article, 2008

de Blacam C, Gray J, Boyle T, Kennedy MJ, Hollywood D, Butt J, Griffin M, Nicholson S, Dunne B, Wilson G, McDermott R, Murphy P, Short I, Rowley S, Connolly E, Reynolds JV, Breast cancer outcomes following a national initiative in Ireland to restructure delivery of services for symptomatic disease., Breast (Edinburgh, Scotland), 17, (4), 2008, p412-7 Journal Article, 2008

Smith FM, Miller N, Gaffney EF, Stephens RB, Kennedy MJ, Reynolds JV, Looking to the future by creating a blood and tissue 'biobank' from surgical patients, B J Surg, 2007 Journal Article, 2007

Smith FM, Reynolds JV, Miller N, Stephens RB, Kennedy MJ, Pathological and molecular predictors of the response of rectal cancer to neoadjuvant radiochemotherapy, Eur J Surg Oncol, 32, 2006, p55 - 64 Journal Article, 2006

O'Byrne KJ, Kennedy MJ, New targets for therapy in breast cancer: Targeted angiogenesis inhibitors, Breast Cancer Res Treat, 2006 Journal Article, 2006

Smith FM, Reynolds JV, Kay EW, Crotty P, Murphy JO, Hollywood D, Gaffney EF, Stephens RB, Kennedy MJ, COX-2 overexpression in pretreatment biopsies predicts response of rectal cancers to neoadjuvant radiochemtherapy, Int J Radiat Oncol Biol Phys, 64, 2006, p466 - 472 Journal Article, 2006

Reynolds JV, Ravi N, Hollywood DP, Kennedy MJ, Rowley S, Ryan A, Hughes N, Carey M, Byrne P, Neoadjuvant chemoradiation may increase the risk of respiratory, J Thorac Cardiovasc Surg., 132, 2006, p549 - 555 Journal Article, 2006

MacGuill M, Mulligan E, Ravi N, Rowley S, Byrne PJ , Hollywood D, Kennedy MJ, Keeling PW, Reynolds JV, Clinicopathologis factors predicting complete pathologic response to neoadjuvant chemoradiotherapy in esophageal cancer, Dis Esophagus, 29, 2006, p273 - 278 Journal Article, 2006

Wolff A, O Neill A, Kennedy MJ, Stewart JA, Gradishar W, Lord RS, Davidson NE, Wood WC, Single-agent topotecan as first-line chemotherapy in women with metastatic breast cancer: Final results of Eastern Cooperative Oncology Group trial E8193, Clin Breast Ca, 6, 2005, p334 - 339 Journal Article, 2005

Smith FM, Coffey JC, Khasri NM, Walsh MF, Parfrey N, Gaffney EF, Stephens RB, Kennedy MJ, Kirwan WO, Redmond HP, Sentinel nodes are identifiable in formalin fixed specimens after surgeon performed, ex-vivo sentinel node lymph node mapping in colorectal cancer, Ann Surg Oncol, 12, 2005, p504 - 509 Journal Article, 2005

Power R, Kennedy MJ, Crown J, Fraser I, Thornhill J, Pelvic recurrence in stage I seminoma: A new phenomenon that questions modern protocols for radiotherapy and follow-up, Int J Urol, 12, 2005, p378 - 382 Journal Article, 2005

Smith FM, Stephens RB, Kennedy MJ, Reynolds JV, P53 abnormalities and outcomes in rectal cancer: a systematic review, B J Cancer, 9, 2005, p1813 - 1813 Journal Article, 2005

Marty M, Cognetti F, Maraninchi D, Snyder R, Mauriac L, Tubiana-Hulin M, Chan S, Grimes D, Anton A, Lluch A, Kennedy MJ, O'Byrne K, Conte P, Green M, Ward C, Mayne K, Extra J-M (on behalf of the M77001 study group), Efficacy and safety of trastuzumab (Herceptin?) combined with docetaxel in patients with HER2-positive metastatic breast cancer given as first-line treatment: results of a randomized phase II trial (M77001), J Clin Oncol, 23, 2005, p4265 - 4274 Journal Article, 2005

Hennessy B, McCaffrey JA, Daly P, Browne P and Kennedy MJ, High dose chemotherapy and stem cell support for poor risk and recurrent non seminomatous germ cell cancer: initial experience with sequential therapy, Ir J Med Sci, 171, 2002, p158 - 160 Journal Article, 2002

Pecora AL, Lazarus HM, Jennnis AA, Preti RA, Goldberg SL, Rowley SD, Cantwell S, Cooper BW, Copelan EA, Herzig RH, Meagher R, Kennedy MJ, Akard LR, Jansen J, Ross A, Prilutskaya M, Glassco J, Kahn D, Moss TJ, Breast cancer cell contamination of blood stem cell products in patients with metastatic breast cancer: predictors and clinical relevance, Biol Blood Marrow Transplant, 8, 2002, p536 - 543 Journal Article, 2002

Kennedy MJ, The limits of tamoxifen, Ir J Med Sci, 171, 2002, p8 - 9 Journal Article, 2002

Emens L, Kennedy MJ, Fetting J, Davidson NE, Garrett E, Armstrong DK, A phase I toxicity and feasibility trial of sequential dose dense induction chemotherapy with doxorubicin, paclitaxel and 5-flourouracil followed by high-dose consolidation for high-risk primary breast cancer, Breast Cancer Res and Treat, 76, 2002, p145 - 165 Journal Article, 2002

O'Connell N, Gardiner N, Duggan C, Enright H, Kennedy MJ, McCann SR, Daly PA, Browne PV, Effective progenitor cell mobilization in lymphoproliferative disorders using ifosfamide, epirubicin and etoposide (IEV), Eur J Haematol Suppl, 64, 2001, p33 - 36 Journal Article, 2001

Cardiovascular Emergencies in Oncology in, editor(s)Spence RAJ and Johnston P , Oncological Emergencies, OUP, 2001, [Shah AR, and Kennedy MJ] Book Chapter, 2001

Heath EI, O'Reilly S, Humphrey R, Sundaresan P, Donehower RC, Sartorius S, Kennedy MJ, Armstrong DK, Carducci MA, Sorensen JM, Kennedy S, Grochow LB, Phase I trial of the matrix metalloproteinase inhibitor BAY12-9566 in patients with advanced solid tumors, Cancer Chemother Pharmacol, 48, 2001, p269 - 274 Journal Article, 2001

Hennessy B, Kennedy MJ, High dose therapy for breast cancer: the European experience, Breast Dis., 14, 2001, p3 - 7 Journal Article, 2001

Bird B, Kennedy MJ, Chemotherapy for Breast Cancer: an Updat, Cancer Topics, 11, 2001, p1 - 4 Journal Article, 2001

Cardiovascular Emergencies in Oncology in, editor(s)Spence RAJ and Johnston P. , Oncological Emergencies, 2001, [Shah AR, and Kennedy MJ] Book Chapter, 2001

Knowles S, Herra C, Devitt E, O'Brien A, Mulvihill E, McCann SR, Browne P, Kennedy MJ, Keane CT, An outbreak of multiply resistant Serratia marcescens: the importance of persistent carriage, Bone Marrow Transplant, 25, 2000, p873 - 877 Journal Article, 2000

Hahm HA, Armstrong DK Chen T, Grochow L, Passos-Coelho J, Goodman S, Davidson N, Kennedy MJ, Novobiocin in combination with high-dose chemotherapy for the treatment of advanced breast cancer: A phase II study, Biology of Blood and Bone Marrow Transplantation, 6, 2000, p335 - 343 Journal Article, 2000

Gaston-Johannson F, Nanda J, Kennedy MJ, The effectiveness of the comprehensive coping strategy progam on clinical outcomes in breast cancer autologous bone marrow transplantation patients, Cancer Nursing, 23, 2000, p277 - 285 Journal Article, 2000

van der Wall E, Horn T, Bright E, Passos-Coehlo JL, Bond S, Clarke B, Altomonte V, McIntyre K, Vogelsang G, Noga SJ, Davis JM, Thomassen J, Ohly KV, Lee SM, Fetting J, Armstrong DK, Davidson NE, Hess AD, Kennedy MJ, Autologous graft-versus-host disease induction in advanced breast cancer: role of peripheral blood progenitor cells, Br J Cancer, 83, 2000, p1405 - 1411 Journal Article, 2000

Gaston-Johansson F, Ohly KV, Fall-Dickson JM, Nanda JP, Kennedy MJ, Pain, psychological distress, health status, and coping in patients with breast cancer scheduled for autotransplantation, Oncol Nurs Forum, 26, 1999, p1337 - 1345 Journal Article, 1999

Mikhak, B, Zahurek M, Beveridge RA, Donehower RC, Fetting JH, Davidson NE, Waterfield WC, Abeloff MD, Kennedy MJ, Long term follow-up of women treated with sixteen-week dose-intense chemotherapy in the adjuvant treatment of high-risk breast cancer, Cancer, 86, 1999, p899 - 904 Journal Article, 1999

Dose Intensive Chemotherapy for Breast Cancer in, editor(s)Harris J, Lippman M, Morrow M, and Osborne CK , Diseases of the Breast, Philadelphia, PA, Lippincott, Williams and Wilkins, Inc, 1999, pp633 - 644, [Davidson NE, and Kennedy MJ] Book Chapter, 1999

Subramanyan S, Bond S, Fetting J, Davidson NE, Kennedy MJ, Phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer, Cancer Chemother Pharmacol, 23, 1999, p497 - 502 Journal Article, 1999

Subramanyan S, Kennedy MJ, Tamoxifen for the prevention of breast cancer in younger women, Current Opinion in Preventive Medicine, 2, 1999, p30 - 34 Journal Article, 1999

Rowlings PA, Williams SF, Antman K, Fay J, Reed E, Pelz, C, Klein J, , Factors correlating with progression-free survival after high dose therapy and hematopoietic stem cell transplantation for metastatic breast cancer, JAMA, 282, 1999, p1335 - 1343 Journal Article, 1999

Dose Intensive Chemotherapy for Breast Cancer. in, editor(s)Harris J, Lippman M, Morrow M, and Osborne CK , Diseases of the Breast., Philadelphia, PA, Lippincott, Williams and Wilkins, 1999, pp633 - 644, [Davidson NE, and Kennedy MJ] Book Chapter, 1999

Gaston-Johansson F, Fall-Dickson JM, Bakos AB, Kennedy MJ, Fatigue, pain, and depression in pre-autotransplant breast cancer patients, Cancer Pract, 7, 1999, p240 - 247 Journal Article, 1999

Dees EC, Kennedy MJ, Recent advances in systemic therapy for breast cancer, Curr Opin Oncol, 10, 1998, p517 - 522 Journal Article, 1998

Kennedy MJ, Zahurak ML, Donehower RC, Noe D, Grochow LB, Sartorius S, Chen, Sequence-dependent hematologic toxicity associated with the 3-hour paclitaxel/cyclophosphamide doublet, Clin Cancer Res, 4, 1998, p1349 - 1356 Journal Article, 1998

Subramanyan S, Kennedy MJ, Breast Cancer: High dose therapy, The Oncologist, 3, 1998, p289 - 299 Journal Article, 1998

Kennedy, MJ, Peripheral blood progenitor cell mobilization: A clinical review, Pharmacotherapy, 18, 1998, p3 - 8 Journal Article, 1998

Kennedy MJ, Systemic therapy of breast cancer, Current Opinion in Oncology, 9, 1997, p532 - 539 Journal Article, 1997

Kennedy, MJ, Vogelsang GB, Jones RJ, Hess AD, Post-transplant immunotherapy by induction of autologous GVHD, Auto Marrow Bld Transplant, 8, 1997, p601 - 608 Journal Article, 1997

Hess AD, Bright EC, Thoburn C, Vogelsang GB, Jones RJ, Kennedy MJ, Specificity of effector T lymphocytes in autologous graft-vs-host disease: Role of the MHC Class II invariant chain peptide, Blood, 89, 1997, p2203 - 2209 Journal Article, 1997

Antman KH, Rowlings PA, Vaughan WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner BE, Holland HK, Kennedy MJ, Klein JP, Lazarus HM, McCarthy PL, Jr, Saez R, Spitzer G, Stadtmauer, EA, Williams Sf, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM, High-dose chemotherapy with autologous hematopoietic stem-cell support for breast cancer in north america, J Clin Oncol, 15, 1997, p1870 - 1879 Journal Article, 1997

Kennedy, MJ, Vogelsang GB, Jones RJ, Hess AD, Post-transplant immunotherapy by induction of autologous GVHD, Auto Marrow Bld Transplant, 8, 1997, p601 - 608 Journal Article, 1997

Kennedy MJ, Issues concerning the inclusion of high-dose chemotherapy in the NCCN breast cancer guidelines, Oncology, 11, 1997, p121 - 126 Journal Article, 1997

Kennedy, MJ, Vogelsang GB, Jones RJ, Hess AD, Post-transplant immunotherapy by induction of autologous GVHD, Auto Marrow Bld Transplant, 8, 1997, p601 - 608 Journal Article, 1997

Protein kinase C and breast cancer in, editor(s)Dickson R and Lippman M , Breast Cancer: Cellular and Molecular Biology V, Kluwer Academic Publishers, 1996, pp91 - 105, [Davidson NE, and Kennedy MJ] Book Chapter, 1996

Kennedy MJ, Zahurak ML, Donehower RC, Noe DA, Sartorius S, Chen T-L, Bowling K, Rowinsky E, Phase I and pharmacologic study of sequences of paclitaxel and cyclophosphamide supported by granulocyte colony stimulating factor in women with previously treated metastatic breast cancer, J Clin Oncol, 14, 1996, p783 - 791 Journal Article, 1996

Passos-Coelho JL, Ross AA, Kahn DJ, Moss TJ, Davis JM, Huelskamp AM, Noga SJ, Davidson NE, Kennedy MJ, Similar breast cancer cell contamination of single-day peripheral blood progenitor cell (PBPC) collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor, J Clin Oncol, 14, 1996, p2569 - 2575 Journal Article, 1996

Breast cancer in, editor(s)Stobo JD, Hellman DB, Landenson PW, Petty B, and Traill TA , The Principles and Practice of Medicine, Norwalk, CT, Appleton and Lange, Inc., 1996, pp780 - 784, [Kennedy MJ, and Abeloff MD] Book Chapter, 1996

Ross AA, Layton TJ, Ostrander AB, Passos-Coelho JL, Davis JM, Huelskamp AM, Noga, SJ, Davidson, Kennedy MJ, Cooper BW, Gerson SL, Lazarus HM, Holland K, Gluck S, Moss MJ, Kaubish A, Vahdat L, Antman K, Comparative analysis of breast cancer contamination in mobilized and nonmobilized hematopoietic Grafts, J Hematother, 5, 1996, p549 - 552 Journal Article, 1996

Miller CB, Piantadosi S, Vogelsang GB, Marcellus DC, Grochow L, Kennedy MJ, Jones RJ, The impact of age on outcome of patients undergoing autologous bone marrow transplantation, J Clin Oncol, 14, 1996, p1327 - 1332 Journal Article, 1996

Anderson LW, Chen T-L, Colvin OM, Grochow LB, Collins JM, Kennedy MJ, Strong JM, Cyclophosphamide and 4-hydroxycyclophophamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy, Clin Cancer Res, 2, 1996, p1481 - 1488 Journal Article, 1996

Kennedy MJ, Metastatic breast cancer, Current Opinion in Oncology, 8, (6), 1996, p485 - 490 Journal Article, 1996

Kennedy MJ, Editorial: High-dose chemotherapy of breast cancer: Is the question answered?, J Clin Oncol, 13, 1995, p2477 - 2479 Journal Article, 1995

Hess AD, Kennedy MJ, Ruvolo PP, Vogelsang GB, Jones RJ, Antitumor activity of syngeneic/autologous graft-vs-host disease, Ann NY Acad Sci, 770, 1995, p189 - 202 Journal Article, 1995

Jones RJ, Kennedy MJ, Hess AD, Autologous graft-versus-host disease, Bone Marrow Trans, 15, 1995, pS119 - S123 Journal Article, 1995

Chen TL, Passos-Coelho JL, Noe DA, Kennedy MJ, Black KC, Colvin OM, Grochow LB, Nonlinear pharmacokinetics of cyclophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation, Cancer Res, 55, 1995, p810 - 816 Journal Article, 1995

Kennedy MJ, Armstrong DK, Huelskamp AM, Ohly K, Clarke BV, Colvin OM, Grochow LB, Chen T-L, Davidson NE, Phase I and pharmacologic study of the alkylating agent modulator novobiocin in combination with high-dose chemotherapy for the treatment of metastatic breast cancer, J Clin Oncol, 13, 1995, p1136 - 1143 Journal Article, 1995

Passos-Coelho JL, Ross AA, Moss TJ, Davis JM, Huelskamp AM, Davidson NE, Noga SJ, Kennedy MJ, Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection following priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor, Blood, 85, 1995, p1138 - 1143 Journal Article, 1995

Breast Cancer: Bone Marrow Transplantation in, editor(s)Cameron JL , Current Surgical Therapy, Mosby, St. Louis, Missouri, 1995, pp553 - 557, [Kennedy MJ] Book Chapter, 1995

Kennedy MJ, Hess AD, Autologous graft-versus-host disease, Medical Oncology, 12, 1995, p149 - 156 Journal Article, 1995

Passos-Coelho J-L, Braine HG, Davis JM, Huelskamp AM, Schepers KG, Clarke B, Wright SK, Noga SJ, Davidson NE, Kennedy MJ, Predictive factors for peripheral blood progenitor cell (PBPC) collections using a single large volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony stimulating factor (GM-CSF) mobilization, J Clin Oncol, 13, 1995, p705 - 714 Journal Article, 1995

Passos-Coelho JL, Braine HG, Wright SK, Davis JM, Schepers KG, Huelskamp AM, Clarke B, Noga SJ, and Kennedy MJ, Large volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells, J Hematother, 4, 1995, p11 - 20 Journal Article, 1995

Simpson SJ, Vachula M, Kennedy MJ, Kaiser H, Coon JS, Ghalie R, Williams S, Van Epps D, Detection of tumor cells in the bone marrow, peripheral blood and apheresis products of breast cancer patients using flow cytometry, Experimental Hematology, 23, 1995, p1062 - 1068 Journal Article, 1995

Kennedy MJ, Editorial: High-dose chemotherapy of breast cancer: Is the question answered? (Editorial), J Clin Oncol, 13, 1995, p2477 - 2479 Journal Article, 1995

Horn TD, Altomonte V, Vogelsang G, Kennedy MJ, Erythroderma after autologous bone marrow transplantation modified by administration of cyclosporine and interferon gamma for breast cancer, J Am Acad Dermatol, 34, 1995, p413 - 417 Journal Article, 1995

Kennedy MJ, Donehower RC, and Rowinsky EK, Treatment of metastatic breast cancer with the paclitaxel/cyclophosphamide combination, Semin Oncol, 22, 1995, p23 - 27 Journal Article, 1995

Ruvolo P, Bright E, Kennedy MJ, Morris L, Fischer A, Vogelsang G, Jones R, and Hess A, Cyclosporine-induced autologous graft versus host disease: Assessment of cytolytic effector mechanisms and the Vß T-cell receptor repertoire, Trans Proc, 27, 1995, p1363 - 1365 Journal Article, 1995

Breast Cancer: Bone Marrow Transplantation. in, editor(s)Cameron JL , Current Surgical Therapy. , St. Louis, Missouri, Mosby, 1995, pp553 - 557, [Kennedy MJ] Book Chapter, 1995

O'Reilly S, Kennedy MJ, Rowinsky EK, Donehower RC, Vinorelbine and the topoisomerase 1 inhibitors: Current and potential roles in breast cancer chemotherapy, Breast Cancer Res and Treat, 33, 1994, p1 - 17 Journal Article, 1994

Chan DW, Beveridge RA, Bhargava A, Wilcox PM, Kennedy MJ, Schwartz MK, Breast cancer marker CA549: A multi-center study, Am J Clin Pathol, 101, 1994, p465 - 470 Journal Article, 1994

Kennedy MJ, Vogelsang GB, Jones RJ, Farmer ER, Hess AD, Altomonte V, Huelskamp AM, Davidson NE, Phase I trial of interferon-gamma to potentiate cyclosporine A-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer, J Clin Onc, 12, 1994, p249 - 257 Journal Article, 1994

Chen T-L, Kennedy MJ, Dunlap VM, Colvin OM, Determination of plasma novobiocin levels by a reverse-phase high-performance liquid chromatographic assay, J Chromatog, 652, 1994, p109 - 113 Journal Article, 1994

Kennedy MJ, Systemic adjuvant therapy for breast cancer, Current Opinion in Oncology, 6, 1994, p570 - 577 Journal Article, 1994

Passos-Coelho J, Ross AA, Davis JM, Huelskamp AM, Clarke SJ, Davidson NE, and Kennedy MJ, Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: Effect of ex-vivo purging with 4-hydroperoxycyclophosphamide, Cancer Res, 54, 1994, p2366 - 2371 Journal Article, 1994

Kennedy MJ, Induction of graft-versus-host syndrome as a treatment for breast cancer, Clin Immunother, 1, 1994, p173 - 180 Journal Article, 1994

Kennedy MJ, Induced autologous graft-versus-host disease for the treatment of cancer, Cancer Treatment Reviews, 20, 1994, p97 - 103 Journal Article, 1994

Kennedy MJ, Jones RJ, Autologous graft-versus-host: immunotherapy of breast cancer after bone marrow transplantation, Breast Cancer Res Treat, 26, 1993, pS32 - S40 Journal Article, 1993

Kennedy MJ, Vogelsang GB, Beveridge RA, Farmer ER, Altomonte V, Huelskamp AM, Davidson N, Phase I trial of intravenous cyclosporine A to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer, J Clin Oncol, 11, 1993, p478 - 484 Journal Article, 1993

Ross AA, Cooper BW, Lazarus HM, Mackay W, Moss TI, Ciobanu N, Tallman MS, Kennedy MJ, Davidson NE, Sweet D, Winter C, Akard L, Jansen J, Copelan E, Meagher RC, Herzig RH, Klumpp TR, Kahn DG, Warner NE, Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques, Blood, 82, 1993, p2605 - 2610 Journal Article, 1993

Kennedy MJ, Davis J, Passos-Coehlo J, Noga SJ, Huelskamp AM, Ohly K, Davidson NE, Administration of human recombinant granulocyte-colony stimulating factor (G-CSF, Filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide purged marrow in women with metastatic breast cancer, Cancer Res, 53, 1993, p5424 - 5428 Journal Article, 1993

Kennedy MJ, Abeloff MD, Management of locally recurrent breast cancer, Cancer, 71, 1993, p2395 - 2409 Journal Article, 1993

Kennedy MJ, High-dose cytotoxic therapy for breast cancer, Curr Med Lit--Breast Cancer, 4, (3), 1992, p73 - 76 Journal Article, 1992

Antman K, Corringham R, de Vries E, Elfenbein G, Gianni AM, Gisselbrecht C, Herzig R, Juttner C, Kaizer H, Kennedy MJ, et al., Dose intensive therapy in breast cancer. Bone Marrow Transplantation, Bone Marrow Trans, 10, 1992, p67 - 73 Journal Article, 1992

Kennedy MJ, Prestigiacomo LJ, Tyler G, May WS, and Davidson NE, Differential effects of bryostatin 1 and phorbol ester on human breast cancer cell lines, Cancer Res, 52, 1992, p1278 - 1283 Journal Article, 1992

Kennedy MJ, Review of Regulatory Mechanisms in Breast Cancer: Advances in Cellular and Molecular Biology of Breast Cancer, by Lippman ME, Dickson RB , Journal Cancer Inst, 84, 1992, p531-532 Review, 1992

Kennedy MJ, High-dose cytotoxic therapy for breast cancer (Editorial), Curr Med Lit--Breast Cancer, 4, (3), 1992, p73 - 76 Journal Article, 1992

Rowley SD, Piantadosi S, Marcellus DC, Jones RJ, Davidson NE, Davis JM, Kennedy MJ, Wiley JM, Wingard J, Yeager AM, Santos GW, Analysis of factors predicting speed of hematologic recovery after transplantation with 4-hydroperoxycyclophosphamide-purged autologous bone marrow grafts, Bone Marrow Trans, 7, 1991, p183 - 191 Journal Article, 1991

Kennedy MJ, Beveridge RA, Rowley SD, Gordon GB, Abeloff MD, Davidson NE, High-dose chemotherapy with reinfusion of purged autologous marrow following dose-intense induction as initial therapy for metastatic breast cancer, J Natl Cancer Inst, 83, 1991, p920 - 925 Journal Article, 1991

Kennedy MJ, Donehower RC, Grochow LB, Ettinger DS, Fetting JH, and Abeloff MD, Phase II trial of menogaril as initial chemotherapy for metastatic breast cancer, Invest New Drugs, 8, 1990, p289 - 294 Journal Article, 1990

O'Briain DS, Kennedy MJ, Daly PA, O'Brien AAJ, Tanner WA, Rogers P, and Lawlor E, Multiple lymphomatous polyposis of the gastrointestinal tract: A clinicopathological distinctive form of non hodgkin's lymphoma of B cell centrocytic type, Am J Surg Pathol, 13, 1989, p691 - 699 Journal Article, 1989

Kennedy MJ, Daly PA, Lawlor E, O'Briain DS, Relapsing large cell immunoblastic lymphoma complicating well differentiated lymphocytic lymphoma: A report of two cases showing survival with therapy, Clin Lab Haematol, 10, 1988, p7 - 14 Journal Article, 1988

Kennedy MJ, Eustace P, O'Briain DS, and Daly PA, Paraneoplastic papilloedema and neuroblastoma, Postgrad Med J, 63, 1987, p873 - 876 Journal Article, 1987

Kennedy MJ, Shelley RK, and Daly PA, Potentiation of small cell lung cancer related SIADH by trifluoperazine, Eur J Respir Dis, 71, 1987, p450 - 454 Journal Article, 1987